Updates on role of human recombinant activated protein C in patients with sepsis and severe sepsis: Changed scenario after PROWESS SHOCK trial

Eitemau Tebyg

• Severe sepsis: are PROWESS and PROWESS-SHOCK trials comparable? A clinical and statistical heterogeneity analysis
  gan: Kalil, Andre C, et al.
  Cyhoeddwyd: (2013)
• Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients
  gan: Martí‐Carvajal, Arturo J, et al.
  Cyhoeddwyd: (2012)
• Role of human recombinant activated protein C and low dose corticosteroid therapy in sepsis
  gan: Shukla, Aparna, et al.
  Cyhoeddwyd: (2010)
• Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes
  gan: Martin, Greg S
  Cyhoeddwyd: (2012)
• Steroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated)
  gan: Levy, Howard, et al.
  Cyhoeddwyd: (2005)